This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2017-12-20 SGB Conference Call"

From HL7Wiki
Jump to navigation Jump to search
Line 144: Line 144:
 
**V2 management group
 
**V2 management group
 
***Lorraine notes that it has been surfaced at OO and they are working on scheduling a discussion in New Orleans. Will announce schedule at cochair dinner.
 
***Lorraine notes that it has been surfaced at OO and they are working on scheduling a discussion in New Orleans. Will announce schedule at cochair dinner.
**[http://wiki.hl7.org/index.php?title=List_of_Precepts_Under_Development Precepts We Need to Develop]
+
*Adjourned at 11:03 AM Eastern
 
 
 
 
  
 
===Meeting Outcomes===
 
===Meeting Outcomes===

Revision as of 21:40, 21 December 2017

back to Standards Governance Board main page

HL7 SGB Minutes

Location:
https://global.gotomeeting.com/join/538465637

Date: 2017-12-20
Time: 10:00 AM Eastern
Facilitator Paul/Calvin Note taker(s) Anne
Attendee Name


x Calvin Beebe
x Lorraine Constable
x Russ Hamm
x Tony Julian
x Paul Knapp
x Austin Kreisler
x Wayne Kubick
Thom Kuhn
Ken McCaslin
x Rik Smithies
x Sandy Stuart
Quorum: Chair + 4

Agenda

  • Agenda review
  • Approve Minutes of 2017-12-13_SGB_Conference_Call
  • Action Items
    • Paul to ask Vocab to approve a motion that it was the WG’s intention in R3 for the Expansion profile to be balloted as STU. If PA has not documented approval, send them the same message
    • Paul to verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
    • Decide on where to post Product Life Cycle document
    • Elect replacement chair for Austin
    • Recruit new provider member
    • Anne to forward CIMI-MG invite letter to marketing/communications to send to membership
      • Complete. Will go out first week of January, after the holidays and after M&C approved
    • Anne to post SGB M&C on website/wiki, and post generic product family M&C in Templates section of website with link from wiki
      • Complete
    • Anne to ask Dave to close substantive change project
      • Complete
  • Discussion Topics
    • New Orleans agenda
      • So far: Short and Long Term Work Plan, Precept on how to bring in large projects
    • Candidates for replacement chair
    • Backwards compatibility consistency and definition across families
    • Separation of concerns re: FHIR
    • Precepts We Need to Develop
  • Parking Lot
    • Review GOM with respect to where SGB and precepts should be reflected
    • How do we deal with making sure that WGs involve those whose content domain they’re touching? (CIMI and Pharmacy and Lab models)
    • FHIR Product Director Position Description: we should 1) review further and draft feedback, then 2) map back the description to the role of FGB
    • Drafting Shared Product Management Responsibilities
    • Levels of standards
    • Separation of concerns
    • Ownership of content
    • ISM
    • Ask methodology groups to define how the definition of substantive change applies to their product family; management groups must then operationalize

Minutes

  • Agenda review
  • Approve Minutes of 2017-12-13_SGB_Conference_Call
    • MOTION to approve: Lorraine/Calvin
    • VOTE: All in favor
  • Action Items
    • Paul to ask Vocab to approve a motion that it was the WG’s intention in R3 for the Expansion profile to be balloted as STU. If PA has not documented approval, send them the same message
      • Carry forward
    • Paul to verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
      • Carry forward
    • Decide on where to post Product Life Cycle document
      • ACTION: Anne to add to Draft documents section
      • Lorraine notes that Dave Shaver will be stepping down from FGB after his term ends, so they'll be looking for a replacement vendor member and also a replacement chair. Discussion over who recommends new members - SGB, CTO, TSC? May need to update FGB's M&C since SGB didn't exist when that was written. Discussion over whether or not Calvin will be on FGB in the new year. May need to look for a vendor member and a provider member. Discussion over adding remaining FGB members into SGB at this point. Paul notes we wouldn't cover the marketing scope. Could have a separate group to handle that. Lorraine notes that they aren't really using FGB for that anyway. Seems to be happening in FHIR Foundation/FHIR.org.
        • ACTION: Austin to discuss with Grahame and Wayne on 2017-01-08 with goal to formalize in New Orleans
    • Elect replacement chair for Austin
      • Lorraine would volunteer if she isn't chairing FGB. If the groups fold together, then it would work. Will hold off on the decision until the issue is decided. Austin agrees to continue on a temporary basis until a new co-chair is named.
    • Recruit new provider member
      • Calvin has decided to remain for a bit, so this is unnecessary. Sandy and Thom also cover provider side.
    • Anne to forward CIMI-MG invite letter to marketing/communications to send to membership
      • Complete. Will go out first week of January, after the holidays and after M&C approved
    • Anne to post SGB M&C on website/wiki, and post generic product family M&C in Templates section of website with link from wiki
      • Complete
    • Anne to ask Dave to close substantive change project
      • Complete
  • Discussion Topics
    • New Orleans agenda
      • So far: Short and Long Term Work Plan, Precept on how to bring in large projects
      • Q2 on Sunday, Q1&2 on Friday.
      • Sunday: ISM work
      • Friday: Short/long term work plan, RDAM/projects referencing SOLOR re: licensing issues (with HTA, 30 minutes in Q2)
    • Candidates for replacement chair
      • Carry forward
    • Backwards compatibility consistency and definition across families
      • Carry forward
    • Separation of concerns re: FHIR
      • Carry forward
    • V2 management group
      • Lorraine notes that it has been surfaced at OO and they are working on scheduling a discussion in New Orleans. Will announce schedule at cochair dinner.
  • Adjourned at 11:03 AM Eastern

Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items

© 2017 Health Level Seven® International. All rights reserved